Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Kohler

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Advances in Therapy|August 25, 2019
Effect of Empagliflozin on Free Fatty Acids and Ketone Bodies in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled TrialRimei Nishimura, Yuko Tanaka, Kazuki Koiwai, et al.
Annals of Transplantation|December 17, 2009
Aspergillus spondylodiscitis after multivisceral transplantationUndine A Gerlach, Sven Kohler, Igor M Sauer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 13, 2008
Graft versus host disease after liver transplantation - a single center experience and review of literatureSven Kohler, Andreas Pascher, Guido Junge, et al.
European Journal of Clinical Investigation|March 9, 2011
Long-term outcome of ATG vs. Basiliximab inductionFrank Ulrich, Sebastian Niedzwiecki, Andreas Pascher, et al.
Clinical Transplantation|September 2, 2009
Symptomatic lymphoceles after kidney transplantation - multivariate analysis of risk factors and outcome after laparoscopic fenestrationFrank Ulrich, Sebastian Niedzwiecki, Panos Fikatas, et al.
Journal of Diabetes Investigation|August 13, 2018
Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I-III clinical trialsDaisuke Yabe, Atsutaka Yasui, Linong Ji, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 29, 2008
Donor brain death significantly interferes with tolerance induction protocolsMaja Francuski, Anja Reutzel-Selke, Sascha Weiss, et al.
Stroke|April 8, 2017
Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular RiskBernard Zinman, Silvio E Inzucchi, John M Lachin, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Advances in Therapy|August 25, 2019
Effect of Empagliflozin on Free Fatty Acids and Ketone Bodies in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled TrialRimei Nishimura, Yuko Tanaka, Kazuki Koiwai, et al.
Annals of Transplantation|December 17, 2009
Aspergillus spondylodiscitis after multivisceral transplantationUndine A Gerlach, Sven Kohler, Igor M Sauer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 13, 2008
Graft versus host disease after liver transplantation - a single center experience and review of literatureSven Kohler, Andreas Pascher, Guido Junge, et al.
European Journal of Clinical Investigation|March 9, 2011
Long-term outcome of ATG vs. Basiliximab inductionFrank Ulrich, Sebastian Niedzwiecki, Andreas Pascher, et al.
Clinical Transplantation|September 2, 2009
Symptomatic lymphoceles after kidney transplantation - multivariate analysis of risk factors and outcome after laparoscopic fenestrationFrank Ulrich, Sebastian Niedzwiecki, Panos Fikatas, et al.
Journal of Diabetes Investigation|August 13, 2018
Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I-III clinical trialsDaisuke Yabe, Atsutaka Yasui, Linong Ji, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 29, 2008
Donor brain death significantly interferes with tolerance induction protocolsMaja Francuski, Anja Reutzel-Selke, Sascha Weiss, et al.
Stroke|April 8, 2017
Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular RiskBernard Zinman, Silvio E Inzucchi, John M Lachin, et al.
Pageof 2